Shaping the treatments of tomorrow

Shaping the treatments of tomorrow



August 2023

Drawing on deep therapy area expertise and forecasting data, Clarivate analysts have selected 15 Drugs to Watch in 2023 – key therapeutics nearing approval that, if green-lighted, are likely to be clinical and/or commercial game-changers. These therapeutics hold the potential to reshape the competitive landscape in their categories and deliver better outcomes to patients. This report can help pharmas and biotechs understand:

• What the near-term pipeline of innovative treatments looks like and how these treatments could answer unmet patient needs

• Where investment is flowing in the life sciences and what technologies and modalities companies are placing bets on

• Who some of the emerging biotechs building out these platforms are and what companies they’re partnering with as they seek to take their innovations to market.